Loading
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Previous close
$5.42
−$0.03 · -0.55%
Regular session · ET · Market data may be delayed.
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Day range
Current $5.42
52-week range
Current $5.42
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Hold
Wait — insufficient conviction to act
Valuation
69
Undervalued
Sentiment
53
Mixed
Risk
57
Elevated Risk
Momentum
35
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Day range
Current $5.42
52-week range
Current $5.42
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 348.67M USD | 335.71M USD | 315.66M USD | 377.24M USD | 358M USD |
| Cost of goods sold | 182.78M USD | 180.96M USD | 188.96M USD | 223.71M USD | 181.52M USD |
| Gross profit | 165.89M USD | 154.74M USD | 126.7M USD | 153.53M USD | 176.48M USD |
| Research and development | 19.4M USD | 21.61M USD | 20.84M USD | 21.94M USD | 16.58M USD |
| Selling, general, and administrative | 165.07M USD | 175.65M USD | 182.35M USD | 164.67M USD | 150.67M USD |
| Operating expenses | 196.1M USD | 197.26M USD | 236.09M USD | 238.78M USD | 167.24M USD |
| Interest income | 2.15M USD | 5.19M USD | 6.57M USD | 2.84M USD | 129K USD |
| Depreciation and amortization | 20.66M USD | 21M USD | 18.15M USD | 23.51M USD | 21.63M USD |
| Operating income | −30.21M USD | −42.52M USD | −109.39M USD | −85.24M USD | 9.24M USD |
| Net income | −22.75M USD | −35.89M USD | −102.45M USD | −83.77M USD | −6.33M USD |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI4.77M0.00%2.3T USD0.03%$379.73-0.32%
iShares Russell 2000 ETFIWM3.38M0.00%79.88B USD0.19%$296.01+0.28%
Vanguard Extended Market ETFVXF1.75M0.00%93.7B USD0.05%$242.66+0.14%
iShares Russell 2000 Value ETFIWN1.16M0.01%14.47B USD0.24%$224.62+0.40%
Vanguard Russell 2000 ETFVTWO887.66K0.00%17.4B USD0.06%$119.62+0.25%
Federated Hermes MDT Small Cap Core ETFFSCC512.01K0.12%360.9M USD0.50%$35.71+0.27%
U.S. Micro Cap Portfolio ETFDFMC460.91K0.01%7.81B USD0.43%$60.36+0.60%
iShares Micro-Cap ETFIWC450.81K0.03%1.47B USD0.60%$196.25+0.69%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Value ETFIWNVanguard Russell 2000 ETFVTWOFederated Hermes MDT Small Cap Core ETFFSCCU.S. Micro Cap Portfolio ETFDFMCiShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
